Skip to main content
logo
Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
31.50
-0.47 (-1.47%)
At close: Sep 18, 2026, 4:00 PM EDT
32.13
+0.63 (2.00%)
After-hours: Sep 18, 2026, 7:45 PM EDT

Zenas BioPharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
110550-
Revenue Growth
-93.33%100.00%-90.00%--
Cost of Revenue
213.47168.06139.1460.0361.69
Gross Profit
-212.47-158.06-134.14-10.03-61.69
Selling, General & Admin
61.4353.3229.7517.1113.51
Operating Expenses
61.4353.3229.7517.1113.51
Operating Income
-273.9-211.39-163.89-27.15-75.2
Interest Expense
-24.26-7.33---
Interest & Investment Income
15.6412.157.97--
Currency Exchange Gain (Loss)
0.30.3-0.1-
Other Non Operating Income (Expenses)
-0.270.120.20.52-43.08
EBT Excluding Unusual Items
-282.49-206.14-155.71-26.52-118.28
Other Unusual Items
---0.85-0.3-
Pretax Income
-484.16-377.82-156.56-36.82-119.28
Income Tax Expense
0.22-0.080.430.3-
Net Income
-484.38-377.74-156.99-37.12-119.28
Net Income to Common
-484.38-377.74-156.99-37.12-119.28
Net Income Growth
-----
Shares Outstanding (Basic)
54451321
Shares Outstanding (Diluted)
54451321
Shares Change
60.52%238.89%762.01%2.61%-
EPS (Basic)
-9.05-8.44-11.89-24.25-79.94
EPS (Diluted)
-9.05-8.44-11.89-24.25-79.94
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-225.97-172.35-119.81-30.55-65.85
Free Cash Flow Per Share
-4.22-3.85-9.08-19.95-44.13
Gross Margin
----20.07%-
Operating Margin
-27390.10%-2113.85%-3277.76%-54.29%-
Profit Margin
-48438.40%-3777.37%-3139.76%-74.25%-
Free Cash Flow Margin
-22597.40%-1723.51%-2396.10%-61.09%-
EBITDA
-273.87-211.33-163.75-27.03-75.12
EBITDA Margin
----54.07%-
D&A For EBITDA
0.030.060.140.110.08
EBIT
-273.9-211.39-163.89-27.15-75.2
EBIT Margin
----54.29%-
Revenue as Reported
110550-
SEC Filings: 10-K · 10-Q